AU1776501A - Bifunctional molecules and their use in the disruption of protein-protein interactions - Google Patents
Bifunctional molecules and their use in the disruption of protein-protein interactionsInfo
- Publication number
- AU1776501A AU1776501A AU17765/01A AU1776501A AU1776501A AU 1776501 A AU1776501 A AU 1776501A AU 17765/01 A AU17765/01 A AU 17765/01A AU 1776501 A AU1776501 A AU 1776501A AU 1776501 A AU1776501 A AU 1776501A
- Authority
- AU
- Australia
- Prior art keywords
- protein
- disruption
- bifunctional molecules
- interactions
- protein interactions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001588 bifunctional effect Effects 0.000 title 1
- 230000004850 protein–protein interaction Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16667599P | 1999-11-19 | 1999-11-19 | |
| US60166675 | 1999-11-19 | ||
| PCT/US2000/031695 WO2001036612A1 (en) | 1999-11-19 | 2000-11-17 | Bifunctional molecules and their use in the disruption of protein-protein interactions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1776501A true AU1776501A (en) | 2001-05-30 |
Family
ID=22604262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU17765/01A Abandoned AU1776501A (en) | 1999-11-19 | 2000-11-17 | Bifunctional molecules and their use in the disruption of protein-protein interactions |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1230353A4 (en) |
| AU (1) | AU1776501A (en) |
| WO (1) | WO2001036612A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2044001A (en) | 1999-11-19 | 2001-05-30 | Board Of Trustees Of The Leland Stanford Junior University | Targeted bifunctional molecules and therapies based thereon |
| US9428845B1 (en) | 2010-12-28 | 2016-08-30 | Warp Drive Bio, Inc. | Identifying new therapeutic agents |
| US10533016B2 (en) | 2015-01-09 | 2020-01-14 | Revolution Medicines, Inc. | Compounds that participate in cooperative binding and uses thereof |
| JP7411326B2 (en) | 2015-10-01 | 2024-01-11 | ワープ ドライブ バイオ インコーポレイテッド | Methods and reagents for analyzing protein-protein interfaces |
| JP7187318B2 (en) | 2016-04-12 | 2022-12-12 | ギンゴー バイオワークス， インコーポレイテッド | Host Cells Expressing Recombinant Heterologous LAL and Methods for Production of Compounds |
| EP3532633A4 (en) | 2016-10-28 | 2020-09-09 | Ginkgo Bioworks Inc. | COMPOSITIONS AND METHODS OF MAKING COMPOUNDS |
| CN114867735A (en) | 2019-11-04 | 2022-08-05 | 锐新医药公司 | RAS inhibitors |
| JP2022553858A (en) | 2019-11-04 | 2022-12-26 | レボリューション メディシンズ インコーポレイテッド | RAS inhibitor |
| EP4054720A1 (en) | 2019-11-04 | 2022-09-14 | Revolution Medicines, Inc. | Ras inhibitors |
| EP4214209A1 (en) | 2020-09-15 | 2023-07-26 | Revolution Medicines, Inc. | Indole derivatives as ras inhibitors in the treatment of cancer |
| AR125787A1 (en) | 2021-05-05 | 2023-08-16 | Revolution Medicines Inc | RAS INHIBITORS |
| AR127308A1 (en) | 2021-10-08 | 2024-01-10 | Revolution Medicines Inc | RAS INHIBITORS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0804561B1 (en) * | 1993-02-12 | 2009-12-30 | The Board Of Trustees Of The Leland Stanford Junior University | Regulated transcription of targeted genes and other biological events |
| EP1079859B1 (en) * | 1998-05-22 | 2010-07-14 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
-
2000
- 2000-11-17 AU AU17765/01A patent/AU1776501A/en not_active Abandoned
- 2000-11-17 WO PCT/US2000/031695 patent/WO2001036612A1/en not_active Application Discontinuation
- 2000-11-17 EP EP20000980512 patent/EP1230353A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1230353A1 (en) | 2002-08-14 |
| WO2001036612A1 (en) | 2001-05-25 |
| EP1230353A4 (en) | 2002-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU775126C (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| AU2002225356A1 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | |
| AU3620600A (en) | Skin-marking devices and their use | |
| AU2103097A (en) | Cinnoline derivatives and use as medicine | |
| HK1084109A1 (en) | 2-,3-,4-,or 5-substituted-n1-(benzensulfonyl) indoles and their use in therapy 2- | |
| AU2002223599A1 (en) | Pyrimidinone derivatives and their use in the treatment of atherosclerosis | |
| AU2002243246A1 (en) | Cddo-compounds and combination therapies thereof | |
| AU2001240637A1 (en) | Novel imidazotriazinones and the use thereof | |
| AUPQ155799A0 (en) | Therapeutic methods and uses | |
| AU1776501A (en) | Bifunctional molecules and their use in the disruption of protein-protein interactions | |
| AU4117000A (en) | Cosmetic product and its use | |
| AU2837301A (en) | Use of polymeric material in the treatment of hard surfaces | |
| AU2841801A (en) | Triazolotriazinones and the use thereof | |
| AU6002800A (en) | Improvements in and relating to portable disc holders | |
| AU2001261375A1 (en) | Human caspase-12 materials and methods | |
| AU1147801A (en) | Self-propelled cart usable in supermarkets and the like | |
| AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
| AU4755600A (en) | Benzohetero cyclylcyclo hexenones and their use as herbicides | |
| AU5134600A (en) | Full-length molecules expressed in human tissues | |
| AU2136401A (en) | P450rai-2 and related proteins | |
| AU2669201A (en) | Taccalonolides and their use | |
| AU3432900A (en) | Colouring agent and the use thereof | |
| AU3263601A (en) | Heme proteins hemat-HS and hemat-BS and their use in medicine and microsensors | |
| AU3294700A (en) | Self-contained and mobile washstand for recurrent use in medical environment | |
| AU5764399A (en) | Antigen-presenting cells and their use in therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |